Endovascular Thrombectomy Clinical Trials

9 recruiting

Frequently Asked Questions

Common questions about Endovascular Thrombectomy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Effects of Transcranial Magnetic Stimulation After Endovascular Treatment for Acute Ischemic Stroke

Ischemic Stroke, AcuteEndovascular Thrombectomy
Xijing Hospital60 enrolled1 locationNCT06639360
Recruiting
Not Applicable

A Multicenter, Randomized Controlled Clinical Investigation to Evaluate the Safety and Effectiveness of the Super-Bore 8/7F Aspiration Catheters in the Treatment of Acute Intracranial Large Vessel Occlusion

Acute Ischemic StrokeEndovascular Thrombectomy
The First Affiliated Hospital of University of Science and Technology of China360 enrolled1 locationNCT06559475
Recruiting
Not Applicable

AI-Driven CTA Reconstruction for Intracranial LVO

Artificial Intelligence (AI)Acute Ischemic StrokeCT Angiography+1 more
Shanghai Jiao Tong University Affiliated Sixth People's Hospital174 enrolled2 locationsNCT06645405
Recruiting
Not Applicable

Evaluation of Endovascular Treatment in Acute Intracranial Distal Medium Vessel Occlusion Stroke

Acute Ischemic StrokeEndovascular Thrombectomy
The First Affiliated Hospital of University of Science and Technology of China564 enrolled1 locationNCT06146790
Recruiting
Not Applicable

Effects of Post-Operative Sedation for Endovascular Thrombectomy

Acute Ischemic StrokeEndovascular Thrombectomy
RenJi Hospital1,286 enrolled1 locationNCT04517383
Recruiting
Not Applicable

Patient Selection Using MR With Non-Perfusion Imaging for Endovascular Treatment Within 6 to 24 Hours

Endovascular Thrombectomy
Tianjin Huanhu Hospital352 enrolled1 locationNCT05735301
Recruiting

Triage of Patients Presenting Beyond 24 Hours With Acute Ischemic Stroke Due to Large Vessel Occlusions (TRACK-LVO Late)

Acute Ischemic StrokeLarge Vessel OcclusionEndovascular Thrombectomy
Tianjin Huanhu Hospital1,000 enrolled1 locationNCT06200753
Recruiting

Medical Imaging Screening for Posterior-circulation Ischemic Stroke

Endovascular Thrombectomy
Tianjin Huanhu Hospital1,000 enrolled4 locationsNCT06094569